Skip to main content
. 2018 Jun 13;109(7):2221–2234. doi: 10.1111/cas.13633

Figure 1.

Figure 1

Expression of ONECUT‐2 (OC‐2) in ovarian cancer samples with different differentiation. A, OC‐2 expression level was analyzed by Western blot in different ovorian cancer cells; *P < .05, **P < .01. B, (a‐f) OC‐2 expression levels in highly differentiated ovarian cancer samples. (a) Serous adenocarcinoma. (b) Serous papillary carcinoma. (c) Serous adenocarcinoma. (d) Serous adenocarcinoma. (e) High‐grade serous adenocarcinoma. (f) Serous adenocarcinoma. (g‐j) OC‐2 expression in poorly differentiated ovarian cancer samples. (g) Moderately differentiated adenocarcinoma. (h) Clear cell carcinoma. (i) Poorly differentiated adenocarcinoma. (j) Poorly differentiated adenocarcinoma. (k,l) OC‐2 expression levels in normal ovarian tissue. Magnification, ×400